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PURPOSE. To evaluate chromatic sensitivity in patients with age-related macular degeneration
(AMD) characterized by drusen and reticular pseudodrusen. To investigate whether the
severity of color vision loss can distinguish between various stages of AMD and hence be used
as an index of progression toward advanced AMD.
METHODS. Chromatic sensitivity was measured by using the Color Assessment and Diagnosis
(CAD) test in asymptomatic individuals with early and intermediate AMD and compared to
normative data. All study participants had logMAR visual acuity of 0.3 or better. The CAD
thresholds measured in eyes with and without reticular pseudodrusen were also compared
and related to central macular thickness (CMT). Student’s t-test P values < 0.05 were
considered significant.
RESULTS. All early- and intermediate-AMD eyes (n ¼ 90) had chromatic sensitivity loss in either
RG (red/green) or YB (yellow/blue), or both (P < 0.0001) as compared to age-matched
normal subjects. The eyes exhibited a range of CAD thresholds affecting both color
mechanisms, but YB color thresholds were in general higher than RG thresholds (P < 0.001).
Intermediate-AMD patients exhibited large intersubject variability. In general, eyes with
reticular pseudodrusen and eyes with CMT < 200 lm had significantly higher CAD
thresholds.
CONCLUSIONS. The anatomic integrity of cone photoreceptors remains relatively unaffected in
early and intermediate stages of AMD. The processing of cone signals in the retina can,
however, be heavily disrupted with subsequent loss of both YB and RG chromatic sensitivity.
The greatest losses were observed in eyes with reticular pseudodrusen.
Keywords: reticular pseudodrusen, functional markers, soft drusen
Early signs of age-related macular degeneration (AMD), oftencharacterized by drusen and pigmentary changes in the
macula, are found in ~8% of people older than 50 years. The
global prevalence of the sight-threatening, late AMD, which
includes geographic atrophy (GA) and choroidal neovascular-
isation (CNV), is less than 0.4%.1 Early AMD is characterized by
the presence of medium-sized drusen (with typical dimension
>63 and <125 lm) without pigmentary abnormalities.
According to Beckman’s classification,2 eyes with large drusen
or with pigmentary abnormalities associated with at least
medium drusen are described as falling within the ‘‘intermedi-
ate’’ AMD group. The risk of progressing to late AMD over 5
years is 50% for patients of highest risk in the intermediate-AMD
group.2 Classification based on color photographs or biomi-
croscopy alone ignores changes relevant to the disorder such as
retinal pigment epithelium (RPE) dysfunction, diminished
photoreceptor function, or the development of reticular
pseudodrusen (RPD). These subtle changes may, however,
affect sensitivity for processing different stimulus attributes,
even in the early stages of disease when visual acuity remains
relatively normal. Psychophysical tests designed to measure
stimulus-specific loss of visual sensitivity by determining the
relationship between controlled visual stimuli and a subject’s
response can be useful indicators of the functional status of the
photoreceptors and other visual processing stages in the
retina.3
Although accurate assessment of changes in chromatic
sensitivity remains largely unexplored, other vision attributes
such as hyperacuity,4 contrast sensitivity,5 dark adaptation,6 and
microperimetry7 have been studied in AMD with some
correlation between decreased retinal sensitivity and structural
markers derived from spectral-domain optical coherence
tomography (SD-OCT).8,9
With improvements in infrared imaging, the interest in RPD
has increased; these deposits are internal to the RPE and the
presence of RPD is frequently associated with decrease in
scotopic thresholds, suggesting rod dysfunction,6 but the link
to loss of color vision remains unexplored.
Normal color vision (CV) is trichromatic and involves
comparison of signals generated in short wavelength (S),
middle wavelength (M), and long wavelength (L) sensitive
cones. The RG (red/green) channel uses L and M cone signals
whilst YB (yellow/blue) channel uses S-cone signals that are
compared against the sum of L and M signals.10 S cones are less
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numerous in the very central region of the retina and make up
only a small percentage of the cone population.11 Under
optimum conditions, young, normal trichromats require only
0.4% L- and 0.8% M-cone contrast changes to detect RG color
differences (at threshold), but 7% S-cone contrast changes are
needed to reach threshold in the case of YB color differenc-
es.12,13 The high sensitivity for detection of RG or YB color
signals and the large number of stages involved in chromatic
processing makes color assessment particularly suitable for
detecting changes caused by retinal disease. A systematic
review of 15 studies reveals loss of chromatic sensitivity in
diseases of the retina with a tendency toward greater YB loss.14
Other studies15 have also reported a correlation between
changes in chromatic sensitivity and disease progression in
AMD.
The aim of this study was to evaluate whether changes in
chromatic sensitivity measured with the Color Assessment and
Diagnosis (CAD) test could be used as a functional biomarker
in AMD to evaluate functional changes in early and interme-
diate AMD as well as in eyes with RPD.
METHODS
All patients/subjects were recruited from medical retina clinic
at Kings College Hospital, London. The study received
approval from the National Research Ethics Service (NRES)
London-East and City, University of London. The research
followed the tenets of the Declaration of Helsinki and informed
consent was obtained from all subjects. The prospective study
included people aged 50 years and older with early or
intermediate AMD and logMAR visual acuity of 0.3 or better
in the tested eye. Each eye of a subject was recruited
separately, as earlier studies have revealed differences in color
thresholds between the two eyes depending on the severity of
AMD.15 Exclusion criteria included the presence of diabetes
mellitus, glaucoma, and history of congenital color vision
deficiencies. Each eye was examined separately. LOCS II (Lens
Opacities Classification System II) classification16 was used to
grade lenticular opacity and eyes with nuclear sclerosis (N),
cortical (C), and posterior subcapsular (P) cataract more than
NI, CII, and PI were excluded from the study. This is simply
because a significant reduction in retinal illuminance due to
lens opacities can cause a reduction in chromatic sensitivity.17
All patients underwent routine ophthalmic examination, CAD
assessment, fundus photography, and OCT scan of the macula
in the test eye.
The CAD Test
The CAD test isolates the use of color signals, quantifies the
severity of both RG and YB loss of chromatic sensitivity,15 and
is particularly appropriate to use when acquired deficiencies
are involved.18 When assessing YB chromatic sensitivity using
the CAD test, the L- and M-cone signals remain unchanged with
‘‘yellow’’ and ‘‘blue’’ hues being signalled entirely by changes
in S-cone signal.19 The test has been used in several studies
designed to investigate variability in RG and YB chromatic
sensitivity in both normal trichromats (as a function of age) and
in subjects with congenital and/or acquired loss of chromatic
sensitivity.15,20–22 The test uses dynamic luminance contrast
noise to isolate the use of color signals.22
The standard CAD test uses 16 interleaved directions
specified in the CIE 1931 (x, y) color space (Fig. 1a). After
each presentation, the subject’s task is to press one of four
buttons, to indicate the direction of motion of the color-
defined stimulus (Fig. 1b). Mean thresholds measured in this
way in 330 young, healthy normal subjects are used to define
the Standard Normal CAD units for RG and YB color vision. All
thresholds are expressed in CAD units.23 For example, RG or
YB thresholds of 3 CAD units indicate three times the mean
color signal strength expected in young normal trichromats.
FIGURE 1. (a) Color report generated at the end of the test. RG/YB color threshold values are displayed and also plotted in the CIE 1931 (x, y) color
chart. The thresholds are measured with respect to the chromaticity of the gray background field (0.305, 0.323), also known as MacAdam white,
which is close to D65. The middle ellipse plots the age-matched mean thresholds expected in normal, healthy trichromats. The outer and inner
ellipses show the corresponding 62.5r upper and lower normal limits for the subject’s age. The colored symbols show the subject’s RG and YB
thresholds which, in the case of congenital color deficients, extend along the corresponding color confusion bands for protanopes (red),
deuteranopes (green), and tritanopes (blue). Screen dumps from the CAD test are shown in (b).
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The CAD test uses continuous age limits obtained by
examining data from a large sample size of 720 eyes from
individuals 4 to 90 years of age.12 To interpret and analyze the
data, the severity of CV loss was classified according to the
subject’s RG or YB color threshold as shown in Table 1. These
limits are based largely on studies of minimum color vision
requirements carried out within visually demanding occupa-
tions.13
The maximum possible YB CAD thresholds correspond to
~18 CAD units as opposed to maximum RG thresholds of 34
CAD units. The lower upper limit that can be achieved for YB
thresholds is caused by the much larger YB color signals
needed at threshold and the limits imposed by the visual
display, which allows higher saturation for RG than YB.
When only S-cone signals are involved, the YB thresholds
remain relatively independent of absorption of short-wave-
length light by the lens and the macular pigment, provided
sufficient ambient light is available to avoid large reductions in
retinal illuminance for short-wavelength light.24,25 The pres-
ence of lens opacities can cause increased light scatter,
changes in the spectral composition of the light, and reduced
retinal illuminance. Small levels of scattered light, residual
refractive errors, and higher-order aberrations do not, however,
cause significant increases in either RG or YB color thresh-
olds26 because of the large stimulus size and the nature of the
task involved in the CAD test.
The Severity of AMD
Fundus photographs of the central 358 of the retina were used
to assess the severity of the disease, based on the Beckman
classification of AMD2 (Table 2), which classifies large drusen
or pigmentary abnormalities associated with at least medium
drusen to have intermediate AMD.
Optical Coherence Tomography
SD-OCT (Spectralis; Heidelberg Engineering, Heidelberg, Ger-
many) volume scan consisting of a 208 3 208 cube with 49
raster lines, each containing 1064 pixels, separated by 125 lm,
was used to acquire the macular scan centred on the anatomic
fovea.
Central macular thickness (CMT) was available as an
automated calculation on the screen or on the printout of
the measurement. CMT corresponds to approximately 500 lm
of the central region of the ETDRS grid. OCT imaging of
incidental isolated cysts (suggestive of wet AMD) or early
thinning (suggestive of GA) were noted and used to classify
eyes accordingly. OCT observations were also compared
against any fundus change noted on photographs. The scans
were analyzed qualitatively to identify drusen and RPD along
with the fundus photographs (Fig. 2). Infrared reflectance
images of the fundus, acquired alongside the macular scans,
were used to confirm the presence of RPD. Eyes with RPD and
drusen were included in the reticular drusen group.
Drusen are the earliest clinical sign of AMD and are
characterized by their texture (hard or soft), borders (distinct
or indistinct), and size (small [<63 lm], intermediate [>63 lm
and <125 lm], or large [‡125 lm]).27,28 Large, soft, confluent
drusen are associated with a higher risk for development of
advanced AMD.29–31
Reticular drusen or subretinal drusenoid deposits repre-
sent a subphenotype of AMD that was first identified with
blue light fundus photography.32 Sivaprasad et al.33 have
recommended that at least two modalities be used to detect
and confirm the diagnosis of RPD. Currently, SD-OCT and
infrared imaging are preferred for screening of RPD.34–36 RPD
were initially associated with neovascular AMD,37,38 but
recent studies39,40 show they represent a risk factor for
progression to GA.
Statistical Analysis
All statistical tests were carried out by using SPSS V.17.0 (SPSS,
Chicago, IL, USA). Measured RG and YB thresholds in patients
TABLE 1. Severity of CV Loss Classified According to the Subject’s RG/
YB Color Threshold
Subject’s RG or YB
Threshold, CAD Units
Classification Label to
Indicate Severity of Loss
Upper normal limit < threshold  6 Mild
6 < threshold  12 Moderate
12 < threshold  17 Severe
Threshold > 17 Very severe
FIGURE 2. Examples of SD-OCT macular scans showing (a) interme-
diate AMD with no reticular pseudodrusen, (b) eyes with reticular
pseudodrusen, and (c) eyes with intermediate AMD and reticular
pseudodrusen (which were included in the RPD group).
TABLE 2. Clinical Categories for Severity of AMD Based on Beckman’s
Classification Criteria
Grade
AMD
Severity Grade Drusen Size, lm Pigment
0 No signs Absent Absent
1 Normal 63 lm (droplets) Absent
2 Early >63 and 125 (medium drusen) Absent
3 Intermediate >125 (large drusen) Present
4 Late Geographic atrophy/wet AMD
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with AMD were compared against age-matched normative
data.12 The measured thresholds were related to the severity of
AMD grading. Thresholds measured in eyes with RPD were also
compared against those measured in eyes without RPD. The
Student’s t-test was used to determine if the two sets of data
were significantly different from each other. A P value < 0.05
was considered significant.
RESULTS
Chromatic Sensitivity in AMD
The CAD test was performed in 90 eyes of 67 subjects: 26 men,
and 41 women. The mean age of the subjects was 70 years,
ranging from 55 to 88 years. The logMAR visual acuity of the
participants selected for the study ranged from 0.0 to 0.3.
Lenticular opacities in most eyes tested were classified either
as N0, Ctr, P0 (33%) or N0, CI, P0 (33%). The remaining
subjects were either pseudophakic or classified as NI, CI, PI
(according to the LOCS II classification16).
Chromatic Sensitivity Results in Our Study Group
Every eye had either RG or YB thresholds, or both, above the
upper normal limits for the corresponding age.12 The
distribution of thresholds spreads over the whole scale of
severity from just above normal limits to the maximum
chromatic saturation imposed by the limits of the visual
display (i.e., ~ 2.5–36.6 CAD units RG and ~ 2.7–18.21 YB).
The independent ranking of RG and YB thresholds of
AMD eyes, after eliminating those with thresholds above
18.2 CAD units (to account for the maximum possible YB
limit), revealed higher YB thresholds when compared to RG
(P < 0.002). This observation demonstrates clearly that on
average loss of YB sensitivity precedes RG. The linear
regression analysis limited to data below 18.2 CAD units
yielded an r2 value of 0.58 (Fig. 3b). The two thresholds are
therefore correlated, but the YB loss was in general slightly
greater than the RG loss. Three AMD patients with acquired
loss on top of congenital RG deficiency (Fig. 3b) were not
included in this analysis.
The Chromatic Loss in AMD Compared to Age-
Matched Normals
The measured colored thresholds in AMD eyes were signifi-
cantly higher for both RG and YB than for age-matched normal
data (P < 0.0001). The loss of chromatic sensitivity in AMD can
be clearly demonstrated by comparing directly the measured
thresholds against the corresponding age-matched normal RG
and YB thresholds12 (Figs. 4a, 4b).
Correlation Between Clinical Classification Grades
and Loss of Chromatic Sensitivity
Most eyes examined in this study were classified as interme-
diate AMD (n ¼ 70% ~ 78%). Patients in this group had mean
FIGURE 3. Distribution of RG and YB thresholds measured in the study. (a) CAD threshold (RG/YB) from each eye ranked in ascending order,
independent of each other. The thresholds span the full range from just greater than the upper normal limits to the maximum chromatic saturations
possible in the RG and YB directions. The maximum RG chromatic displacement is much larger than what can be achieved along the YB axis, as
larger YB signals are needed at threshold and also owing to limitation of visual display. (b) Relationship between the RG and YB thresholds measured
in the same eye. Most YB thresholds are above the dotted gray line of unity gradient. The results show the correlation between RG and YB
thresholds when limited to values < 18.2 units, the upper limit of chromatic displacement for the YB direction (i.e., YB¼1.95þ1.03*RG, r2¼0.58).
The three patients (shown within the circle) with much larger RG thresholds are highly likely to have congenital RG deficiency in addition to
acquired loss of color vision and have not been included in the study.
FIGURE 4. RG (a) and YB (b) CAD thresholds measured in AMD
patients and plotted as a function of age, together with thresholds
measured in healthy normal trichromats. The normative data are based
on 720 eyes filtered for congenital and acquired color deficiencies.
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thresholds of 10.63 for RG and 9.42 for YB. There was wide
intersubject variation with thresholds spreading across the
whole spectrum of CAD threshold values.
There was no statistically significant difference between
intermediate-AMD and early-AMD group, but the sample size
for early AMD was small (n ¼ 8; see Fig. 5).
CMT data were available in 90 eyes. CAD thresholds for eyes
with CMT values  200 lm were significantly different from
those measured in eyes with CMT values > 200 lm (P < 0.01
for RG and < 0.002 for YB). Eyes noted to have incidental early
GA with good vision showed very severe loss of RG/YB
thresholds.
Chromatic Sensitivity Related to the Presence of
RPD
Seventy-one eyes remained after excluding those with inciden-
tal late AMD and eyes with only pigmentary change, but no
drusen. Of these eyes, 49 had only soft drusen, 20 eyes had
reticular drusen (RPD), and 3 eyes had small drusen (<63 lm)
that was classified as normal aging.
Subjects with reticular drusen had the highest mean CAD
thresholds (i.e., RG ¼ 18.9 and YB ¼ 14 CAD units). Subjects
within the soft drusen group had mean RG thresholds of 7.7
and YB thresholds of 7.9 (Fig. 6). Typical examples are shown
in Figures 7a and 7b.
Both the soft drusen and the RPD groups showed
significantly larger thresholds than the normal group (P <
0.0001). The mean difference between the soft drusen and
RPD groups was also statistically significant (P < 0.0001 for
both RG and YB). The subjects within the reticular drusen
group were significantly more affected than those in the soft
drusen group.
DISCUSSION
Either YB or RG thresholds, or both, were found to be
abnormal in every eye with AMD, when comparison was made
with the upper normal limits for the corresponding age. Color
vision depends on the normal functioning of cone photore-
ceptors and the normal processing of these signals in the
retina. Early changes in the retina that are not detected and
labeled as structural changes when using clinical fundus
imaging techniques may cause loss of chromatic sensitivity,
even when high-contrast visual acuity is spared. The latter is
therefore a poor indicator of the earliest changes in the retina
that must precede the loss of color vision. In addition, the
foveal cone mosaic and the corresponding visual acuity can
remain within normal limits even when the cone density
decreases well below normal values at or near the fovea.41
Rod loss precedes cone loss in 75% of early- and
intermediate-AMD eyes42 and deficits in rod-mediated func-
tions occur in AMD and RPD.33 In spite of these observations,
changes in cone-mediated visual functions such as CV and
rapid flicker sensitivity have been reported in early AMD.
Cones may not therefore function normally or cone signals may
not be processed efficiently in AMD despite unaltered foveal
cone numbers, as evident in histopathologic studies.14
The findings from this study demonstrated that YB loss is on
average greater than RG loss. There was also a greater number
of patients with only YB thresholds above upper normal limits.
This observation is consistent with reports by Verriest43 and
others who have found YB loss to be the most commonly
acquired CV deficiency in macular pathology. It has been
proposed that the damage to the smaller number of S cones
and their pathways is more apparent in diseases of the retina.44
Changes in the metabolic environment of the RPE–photore-
ceptor complex also appear to affect S more than L and M
cones.45 Eisner and her colleagues46,47 have demonstrated in
more than one study that patients who exhibit lower S-cone
sensitivities are associated with high risk of developing wet
AMD.
Our findings also showed that AMD eyes with RPD
exhibited the greatest loss of both RG and YB chromatic
sensitivity. The presence of RPD is a recognized risk factor in
progression to GA or CNV in AMD subjects.48 Significant
FIGURE 5. Spread in RG and YB thresholds within the four groups,
based on the clinical classification criteria: 1 ¼ normal, 2 ¼ early, 3 ¼
intermediate, 4 ¼ late. Individuals’ CAD thresholds of each eye are
plotted for each of the four groups; the whiskers show the 5th and
95th percentile, while the mean values are plotted as an outline square
and the median as a solid black disk for each group. Both indices
increase significantly from the ‘‘normal’’ to the ‘‘late’’ group. Although
routine statistical tests cannot be relied upon when skewed
distributions are involved, the ‘‘late’’ AMD group in eyes with early
GA had more severe loss of both RG and YB color vision as reflected in
the much larger mean and median values. Significant skewness is only
observed in the ‘‘intermediate’’ group, which suggests that the clinical
classification criteria for this group may not be appropriate.
FIGURE 6. Spread in RG and YB thresholds in eyes classed as normal
aging, soft drusen, and those with reticular drusen. The whiskers show
the 5th and 95th percentile, while the mean values are plotted as an
outline square and the median as a solid black disk for each group.
The ‘‘none’’ group included three subjects classed as having changes
attributed to normal aging as well as age-matched normal eyes from
normative database. The RG thresholds in the ‘‘reticular’’ group are
more skewed than the YB thresholds. In general, both the mean and
median values increase significantly in the reticular group in spite of
these asymmetries; there is little doubt that the loss of chromatic
sensitivity is most evident in the ‘‘reticular’’ group.
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histologic changes in eyes with RPD have been reported, and
Spaide49 has found the photoreceptor length reduced to 74.4%
and choroidal thickness reduced to 81.4% of its initial value.
Subretinal drusenoid deposits, a histologic correlate of RPD,
have been found to be localized preferentially around the
perifovea affecting the rods, which are abundant at this
eccentricity. Cones are also not spared completely either, and
high-resolution imaging with large pupils and correction of
higher-order aberrations using adaptive optics also show a
dramatic reduction in cone density over the RPD lesions,
possibly due to change in their orientation, alteration in their
cellular architecture, or even absence of cones themselves.50
These observations suggest that eyes with RPD undergo less
apparent structural changes that precede the presence of CNV
or GA.
One possible hypothesis to account for the specific loss of
color vision is choroidal hypoxia,51 which in turn may be a
cause or consequence of RPD. The photoreceptors are highly
active metabolically, and choroidal hypoxia will undoubtedly
compromise the normal functioning of photoreceptors. This,
in turn, can cause a uniform loss of chromatic sensitivity,
particularly when rods consume more oxygen under mesopic,
low-light-level conditions of ambient lighting.18 In addition to
changes in the normal functioning of cone photoreceptors
with little or no effect on visual acuity, it is highly likely that
choroidal hypoxia also causes changes in the inner retina that
may cause specific loss of chromatic sensitivity.
Most eyes in this study were graded as intermediate AMD,
which include eyes with drusen size >125 lm 6 pigmentary
change. The CAD thresholds in this group spread across the
severity scale with large intersubject variation. This large
variability does suggest the involvement of other factors not
visualized on clinical grading that occur in aging/AMD such as
axonal loss of the distal segment of the optic nerve, decreased
choroidal blood flow, increase in the oxidative stress,
incomplete degradation of cells, and material accumulating
FIGURE 7. (a) Example of eye with soft drusen showing a moderate loss of chromatic sensitivity: (1) fundus photo, (2) OCT scan, and (3) CAD
results. (b) Example of images from eye with reticular drusen showing severe loss of chromatic sensitivity: (1) fundus photo, (2) OCT scan, and (3)
CAD results.
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between the RPE and Bruch’s membrane. Together, these
processes are likely to slow the transfer of fluids and essential
nutrients across Bruch’s membrane. The microenvironment
changes in the retinal and the choroidal space in AMD may not
be detectable in conventional imaging. Although many aspects
of functional vision remain relatively normal, the loss of both
RG and YB color vision can be surprisingly severe in AMD.
Although this conclusion is fully justified by our data, the
correlation with the clinical classification criteria of normal,
early, intermediate, and late is less well demonstrated. This is
largely due to the intersubject variability and the relatively
small number of patients per group. The study was limited in
the number of eyes in early-AMD and late-AMD groups and, as a
result, useful comparisons of the severity of CV loss between
the AMD groups could not be made.
CONCLUSIONS
Patients with AMD can exhibit large loss of both RG and YB
chromatic sensitivity. In some cases, such losses precede
obvious clinical signs and may represent the earliest detectable
functional changes. Patients with RPD exhibited the greatest
loss of chromatic sensitivity. Such losses may turn out to be
sensitive and important indicators of early macular atrophy. In
addition to loss of rod function, which has been demonstrated
in early phases of AMD, this study also revealed the significant
loss of sensitivity to chromatic signals, which indirectly must
implicate the normal functioning of cones and/or the
subsequent processing of cone signals within the retina. These
findings suggest that evaluation of chromatic sensitivity using
the CAD test can be a potential biomarker in AMD, particularly
in RPD.
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